4//SEC Filing
Glenn Jeffrey S 4
Accession 0001209191-20-046449
CIK 0001305253other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 6:28 PM ET
Size
10.1 KB
Accession
0001209191-20-046449
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Purchase
Common Stock
2020-08-11$11.49/sh+5,000$57,463→ 71,355 total - Purchase
Common Stock
2020-08-12$11.28/sh+500$5,638→ 500 total(indirect: By Spouse) - Purchase
Common Stock
2020-08-12$11.44/sh+4,500$51,465→ 5,000 total(indirect: By Spouse)
Holdings
- 460(indirect: By son)
Common Stock
- 151,064(indirect: By Eiger Group International, Inc.)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.445 to $11.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001670382
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 6:28 PM ET
- Size
- 10.1 KB